Drug Discovery and Development
edited by Ana Martinez
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors explores the nature of this promising enzyme, providing a thorough introduction and discussion, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity.
Features:
- Cellular functions
- Neuronal cell biology
- Crystal structures
- Kinase-kinase and site-site interactions in the phosphorylation of tau
- Therapeutic target in human pathology
- Role in stem cells
- Physiology studies
- Development and therapeutic potential of GSK-3 inhibitors
Contents
Cellular Functions of GSK-3
- Glycogen Synthase Kinase-3 - an Introductory Synopsis
- Glycogen-Synthase-Kinase-ß (GSK-3ß) a Key Signaling Enzyme: A Developmental Neurobiological Perspective
- Role of GSK3/Shaggy in neuronal cell biology
- The Crystal Structures of Glycogen Synthase Kinase 3
- Kinase-Kinase and Site-Site Interactions in the Phosphorylation of Tau by GSK-3
GSK3 as a Therapeutic Target in Human Pathology
- GSK-3, a Key Player in Alzheimer’s Disease
- Glycogen Synthase Kinase-3: A Target for Novel Mood Disorder Treatments
- GSK3 and Stem Cells
- Glycogen Synthase Kinase-3: role in Neurodegeneration and Neuroprotection
- Protein Kinase Inhibitors. Assay Development
- Animal Models with Modified Expression of GSK-3 for the Study of Its Physiology and of Its Implications in Human Pathologies
GSK-3 Inhibitors: Development and Therapeutic Potential
- Lithium, the Seminal GSK3 Inhibitor
- Inhibition of GSK3 as Therapeutic Strategy in Disease: Efficacy of AR-A014418
- TDZD’s: Selective And ATP Non Competitive Glycogen Synthase Kinase-3 Inhibitors
- 3-Amino Pyrazoles as Potent and Selective Glycogen Synthase (GSK-3) Inhibitors
- Marine compounds as a new source for Glycogen Synthase Kinase-3 Inhibitors
Index